Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo, Xiangya Hospital, Central South University, China.

Dr. Shilin Luo is a leading expert in neuropharmacology and medicinal chemistry, with a strong academic background in traditional Chinese medicine and modern pharmacology. His research focuses on the pathogenesis of neurodegenerative diseases and the development of innovative drug therapies. Through his work at Xiangya Hospital, Central South University, and previous research at Emory University, he has made significant contributions to understanding neurological disorders. His studies on animal models and risk genes have paved the way for novel treatment strategies, earning him international recognition.

Profile

Scopus

Orcid

 

🎓 Early Academic Pursuits

Dr. Shilin Luo’s journey into the world of medical science began with a deep-rooted passion for understanding the complexities of neurological diseases. He earned his Bachelor’s degree in Chinese Materia Medica from Shenyang Pharmaceutical University, where he developed a strong foundation in traditional Chinese medicine and pharmacology. With an insatiable thirst for knowledge, he further pursued a Ph.D. in Medicinal Chemistry at China Pharmaceutical University, specializing in the research of active ingredients in natural products. Under the mentorship of Prof. Wencai Ye, a distinguished scholar, Dr. Luo honed his expertise in medicinal chemistry, paving the way for groundbreaking discoveries in neuropharmacology.

👨‍🎓 Professional Endeavors

To deepen his expertise, Dr. Luo embarked on postdoctoral research at Emory University’s School of Medicine in the Department of Pathology and Laboratory Medicine. Working under the esteemed Prof. Keqiang Ye, he focused on neurobiology and neuropharmacology, contributing significantly to the understanding of neurodegenerative diseases. His research provided novel insights into the molecular mechanisms underlying neurological disorders, positioning him as a leading figure in the field. He later took on a pivotal role as a professor in the Department of Neurology at Xiangya Hospital, Central South University, where he continues to mentor young scientists and advance medical research.

🧪 Contributions and Research Focus

Dr. Luo’s research is primarily dedicated to uncovering the pathogenesis of neurodegenerative diseases and developing therapeutic interventions. His work in animal models of pathogenic and risk genes for neurological disorders has been instrumental in identifying potential drug targets. By integrating traditional Chinese medicine with modern pharmacology, he has contributed to the development of innovative neuroprotective agents. His studies on the molecular mechanisms of neuronal degeneration have led to promising advancements in combating conditions such as Alzheimer’s and Parkinson’s disease.

🏆 Accolades and Recognition

Throughout his career, Dr. Luo has been widely recognized for his groundbreaking contributions to neuropharmacology. His research has been published in high-impact scientific journals, earning him international acclaim. His dedication to scientific excellence has garnered prestigious awards, and he is frequently invited to deliver keynote lectures at global conferences. His work continues to inspire fellow researchers, solidifying his reputation as a distinguished scientist in neurological drug development.

🏰 Impact and Influence

Dr. Luo’s impact extends beyond the laboratory, as he actively contributes to the medical community through mentorship and collaboration. His efforts in integrating traditional Chinese medicinal principles with cutting-edge pharmacological approaches have opened new avenues for drug discovery. His research findings have not only influenced academic discourse but have also laid the groundwork for potential clinical applications, bringing hope to patients suffering from neurodegenerative diseases.

⚛️ Legacy and Future Contributions

As a visionary scientist, Dr. Luo continues to push the boundaries of neurological research. His commitment to translational medicine aims to bridge the gap between laboratory discoveries and clinical applications. By fostering interdisciplinary collaborations and mentoring the next generation of researchers, he is shaping the future of neuropharmacology.

 

Publication

  • Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity
    Authors: Yujie Zhang, Jie Chen, Yanru Li, Bin Jiao, Shilin Luo
    Year: 2025

 

  • The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential
    Authors: Ruiling Xu, Yuxuan Zhang, Shurui Chen, Yaohui Zeng, Xuan Fu, Ti Chen, Shilin Luo, Xiaojie Zhang
    Year: 2023

 

  • Nonviral delivery systems for antisense oligonucleotide therapeutics
    Authors: Si Huang, Xin-Yan Hao, Yong-Jiang Li, Jun‑Yong Wu, Da-Xiong Xiang, Shilin Luo
    Year: 2022

 

  • The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia
    Authors: Si Huang, Xiaoli Liao, Junyong Wu, Xiaojie Zhang, Yamin Li, Daxiong Xiang, Shilin Luo
    Year: 2022

 

  • Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
    Authors: Not explicitly listed
    Year: 2021

 

  • Polygonatum sibiricum Polysaccharides Protect against MPP‐Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways
    Authors: Si Huang, Haiyan Yuan, Wenqun Li, Xinyi Liu, Xiaojie Zhang, Daxiong Xiang, Shilin Luo, Guodong Zhang
    Year: 2021

 

  • Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer’s Disease
    Authors: Chenxia Sheng, Panpan Xu, Xinyi Liu, Weijun Peng, Daxiong Xiang, Shilin Luo
    Year: 2020

 

  • Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway
    Authors: Not explicitly listed
    Year: 2019

 

  • Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson’s Disease
    Authors: Shilin Luo, Seong Su Kang, Zhi-Hao Wang, Xia Liu, Julia X Day, Zhiping Wu, Junmin Peng, Daxiong Xiang, Wolfdieter Springer, Keqiang Ye
    Year: 2019

 

  • Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile
    Authors: Not explicitly listed
    Year: 2018

 

Conclusion

Dr. Luo’s unwavering dedication to neurological research continues to shape the future of neuropharmacology. His innovative approach, combining traditional medicinal insights with modern scientific advancements, has the potential to revolutionize drug development for neurodegenerative diseases. As a mentor, researcher, and pioneer in his field, his contributions will leave a lasting impact on both academia and clinical medicine, offering hope for more effective treatments in the years to come.

 

Sunita Pokhrel Bhattarai | Cognitive | Best Researcher Award

Published on by Neuroscientists

Dr. Sunita Pokhrel Bhattarai | Cognitive | Best Researcher Award

Dr. Sunita Pokhrel, Bhattarai Ohio State University, United States.

Dr. Sunita Pokhrel Bhattarai, Ph.D., RN, is a distinguished nursing scholar and practitioner with a remarkable academic and professional journey. Her career began with an exceptional academic foundation in nursing, supported by prestigious scholarships. She transitioned seamlessly from clinical excellence in Nepal to advanced research and education in the global arena. Her doctoral research at the University of Rochester, focused on innovative methods for diagnosing acute heart failure, underscores her contributions to cardiovascular nursing. Beyond clinical practice, Sunita has excelled in academia, research coordination, and manuscript review, emphasizing her influence in the global nursing and healthcare community. Her accolades, including diversity and travel grants, reflect her dedication to excellence and equity in healthcare.

Profile

Scholar

🩺 Early Academic Pursuits: A Foundation of Excellence

Sunita Pokhrel Bhattarai, Ph.D., RN, began her academic journey with an unwavering commitment to healthcare and nursing education. From earning her Proficiency Certificate in Nursing on a full government scholarship in Nepal to completing her Bachelor’s in Nursing with a specialization in Community Health, Sunita demonstrated a dedication to academic excellence. Her early research on the knowledge and consequences of teenage marriage in Nepal set the stage for her future pursuits. This strong foundation was further reinforced through her Master’s studies in Emergency and Critical Care Nursing under the Erasmus Mundus Scholarship, where she explored advanced cardiac life support knowledge among critical care nurses.

💼 Professional Endeavors: Leadership in Nursing Practice and Education

Sunita’s professional trajectory reflects a remarkable blend of clinical expertise and academic leadership. She served as a Registered Nurse in Nepal’s premier institutions, including Shahid Gangalal National Heart Centre, where she specialized in cardiac care. Transitioning into academia, she became a Nursing Lecturer at Purbanchan University, imparting her knowledge to future nurses. These roles enriched her understanding of healthcare delivery and education, enabling her to contribute effectively to the global nursing community.

🔬 Contributions to Cardiovascular Research: Bridging Practice and Science

Driven by a passion for advancing cardiovascular care, Sunita’s research focuses on acute heart failure and innovative diagnostic approaches. Her doctoral research at the University of Rochester aimed to estimate left ventricular ejection fraction using ECG, a novel contribution to acute heart failure management. Her involvement in multidisciplinary projects, such as investigating the optimal timing for coronary angiography, highlights her ability to bridge clinical practice and scientific inquiry. Her research not only addresses critical clinical questions but also emphasizes the importance of evidence-based solutions in nursing.

🏆 Accolades and Recognition: Celebrating a Trailblazer

Sunita’s outstanding contributions have been recognized with numerous awards and grants. Notable honors include the Presidential Stronger as One Diversity Award from the University of Rochester and the Ireta Neumann Scholarship for International Nurses. Her achievements underscore her dedication to fostering diversity and excellence in nursing. Travel grants from esteemed organizations like the American Heart Association and the International Society for Computerized Electrocardiology further reflect her active participation in the global research community.

🌍 Impact and Influence: Advancing Global Health Equity

Sunita’s work extends beyond research and practice to address disparities in healthcare delivery. With a keen interest in self-care, implementation science, and healthcare discrepancies, she aims to enhance patient outcomes and equity in access to care. Her contributions as a research lead coordinator and manuscript reviewer illustrate her influence in shaping nursing science. Through mentorship and scholarly collaboration, she continues to inspire the next generation of healthcare professionals.

🧠 Legacy of Expertise: Pioneering Big Data and Applied Statistics

Sunita’s proficiency in big data analysis and applied statistics distinguishes her as a thought leader in nursing research. By leveraging these tools, she has contributed to clinical trials and comprehensive literature reviews that inform evidence-based practice. Her role as an abstract reviewer and researcher underscores her commitment to advancing knowledge in cardiovascular nursing and beyond.

🌟 Future Contributions: A Vision for Transformative Healthcare

With her multifaceted expertise and global perspective, Sunita is poised to drive innovation in healthcare. Her dedication to improving acute heart failure diagnostics, addressing healthcare disparities, and mentoring emerging scholars positions her as a transformative figure in nursing science. Her journey is a testament to the power of perseverance, scholarship, and a passion for improving lives.

📚 Publications

  • Delays in door-to-diuretic time and 1-year mortality among patients with heart failure
    Authors: DJ Dzikowicz, SP Bhattarai, J Ng, AL Zemanek, MG Carey
    Year: 2022

 

  • Signs and Symptoms Clusters Among Patients With Acute Heart Failure: A Correlational Study
    Authors: S Pokhrel Bhattarai, DJ Dzikowicz, MG Carey
    Year: 2023

 

  • Integrative review of electrocardiographic characteristics in patients with reduced, mildly reduced, and preserved heart failure
    Authors: SP Bhattarai, RC Block, Y Xue, DH Rodriguez, RG Tucker, MG Carey
    Year: 2024

 

  • Knowledge and practices on prevention of coronary artery diseases in Nepalese community: A cross-sectional from five different cities in Nepal
    Authors: SP Bhattarai, P Neupane
    Year: 2018

 

  • Estimating Ejection Fraction from the 12 Lead ECG among Patients with Acute Heart Failure
    Authors: SP Bhattarai, DJ Dzikowicz, Y Xue, R Block, RG Tucker, S Bhandari, …
    Year: 2024

 

  • Door-to-Diuretic Time is related to length of hospital stay independent of diuretic dose among acute decompensated heart failure patients
    Authors: DJ Dzikowicz, M Aktas, SP Bhattarai, L Chen, MG Carey
    Year: 2025

 

  • Estimating very low ejection fraction from the 12 Lead ECG among patients with acute heart failure
    Authors: SP Bhattarai, DJ Dzikowicz, Y Xue, R Block, RG Tucker, S Bhandari, …
    Year: 2025

 

  • Association Between Serum Albumin and the Length of Hospital Stay Among Patients With Acute Heart Failure
    Authors: S Pokhrel Bhattarai, DJ Dzikowicz, MG Carey
    Year: 2025

 

  • Estimating ejection fraction from the 12 lead ECG in acute heart failure
    Authors: SB Pokhrel, DJ Dzikowicz, S Bhandari, VE Boulware, MG Carey
    Year: 2024

 

  • Interaction Between Door To Diuretic Time And Dosing As A Predictor Of Mortality And Readmission
    Authors: D Dzikowicz, SP Bhattarai, L Chen, MG Carey
    Year: 2024

 

Conclusion

Dr. Sunita Pokhrel Bhattarai’s journey illustrates the power of knowledge, resilience, and a commitment to improving healthcare. By integrating clinical expertise, innovative research, and global collaboration, she has advanced the field of cardiovascular nursing and inspired future generations. Her ongoing work promises to bridge gaps in healthcare delivery, enhance patient outcomes, and drive transformative change in nursing science. Sunita’s legacy is one of impact, innovation, and an enduring dedication to the betterment of global health.

Md Shimul Bhuia | Drug development of neurodegenerative disease | Young Scientist Award 

Published on by Neuroscientists

Mr. Md Shimul Bhuia | Drug development of neurodegenerative disease | Young Scientist Award 

Mr. Md Shimul Bhuia , BioLuster Research Center Limited,  Bangladesh.

An accomplished pharmacist and researcher with expertise in pharmaceutical sciences, molecular docking, and drug development. Awarded the prestigious National Science and Technology Fellowship (NST) in 2023 for contributions to science. Extensive experience includes an internship at Beximco Pharmaceuticals, part-time pharmacy practice, and a full-time role as Deputy Director at BioLuster Research Center. Proficient in advanced software for computational drug design and well-versed in research methodologies. Fluent in Bangla and highly proficient in English, with strong technical and analytical skills.

 

profile

scholor

🎓 Education and Academic Achievements

Master of Pharmacy (M. Pharm.) Department of Pharmacy, Life Science Faculty. Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj-8100, Bangladesh Session: 2020–2021 Course Duration: 1.5 years (3 Semesters)Passing Year: 2022 CGPA: 3.74 (out of 4.00). Bachelor of Pharmacy (B. Pharm.) Department of Pharmacy, Life Science Faculty .Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj-8100, BangladeshSession: 2016–2017  Course Duration: 4 years Hon’s (8 Semesters) Passing Year: 2020 CGPA: 3.45 (out of 4.00)  Higher Secondary Certificate (H.S.C.)  Shahid Bul Bul Govt. College, Pabna Board: Rajshahi Group: Science Passing Year: 2016 GPA: 5.00 (out of 5.00) Secondary School Certificate (S.S.C.) Kamal Pur T.M. High School, Ishwardi, Pabna Board: Rajshahi  Group: Science Passing Year: 2013 GPA: 5.00 (out of 5.00).

🎯 Research Interests

Neurology/Neurodegenerative Diseases , Immunology ,  Cancer Therapy , Toxicology , Molecular Docking , Drug Design and Development via Computational Studies ,Pharmacological Investigation through Preclinical Test Systems , Inflammatory Diseases , Bioinformatics , Anti-cancer Agents

🏆 Honours and Awards

National Science and Technology Fellowship (NST), 2023. Awarded by the Ministry of Science and Technology, Government of Bangladesh

💼 Work Experiences

InternshipBeximco Pharmaceutical Ltd., Squibb Road, Tongi, Bangladesh Duration: November 13, 2022, to November 23, 2022. Pharmacist Worked as a pharmacist at Gafur Chikitsaloi (local pharmacy shop)Employee Status: Part-Researcher Deputy Director, BioLuster Research Center, Gopalganj 8100, Dhaka, Bangladesh Employee Status: Full-time (January 01 – Present)

📚 Publications

 

 Conclusion

With a strong foundation in both clinical practice and academic leadership, Leila Sadati’s career reflects a commitment to advancing healthcare education and patient safety standards. Her contributions in research, curriculum development, and operational management have shaped future medical professionals and enhanced patient care practices. As she continues to innovate and educate, her work remains instrumental in raising the standards of medical and surgical education in Iran and beyond.

 

 

Mohammad Satarzadeh | Cognitive impairments | Best Researcher Award

Published on by Neuroscientists

Mr. Mohammad Satarzadeh | Cognitive Impairments | Best Researcher Award

Mr. Mohammad Satarzadeh Hormozgan medical science university Iran

Mohammad Satarzadeh, born in March 1999 in Arak, is a dedicated nursing graduate with a passion for medicine and healthcare. He completed his Bachelor’s in Nursing from Hormozgan University of Medical Sciences, scoring 16.60 out of 20, and previously attended Payame Noor University for Cellular and Molecular Biology. Fluent in Persian and conversational in both French and Arabic, he is also working towards improving his English for IELTS.

 

profile

scopus

EDUCATION 🎓

Bachelor of Cellular and Molecular BiologyPayame Noor University, Arak (2018–2019)After completing two semesters, I decided to pivot my focus and applied to the University of Medical Sciences.Bachelor of NursingHormozgan University of Medical Sciences, Bandar Abbas (2019–2023)Total Score: 16.60/20

 

EXPERIENCE 📝

I have contributed to several research articles in reputable journals, showcasing my dedication to scientific inquiry:Shigella Antibiotic Resistance in Pediatric Shigellosis Infection: A retrospective study in Hormozgan (Corresponding author, ISI indexed)New Dimension of Epilepsy Complications: A systematic review of visual and retinal disorders (Corresponding author, under review, ISI indexed in BMC Ophthalmology)Maternal Smoking during Pregnancy and Its Effects on Neural Tube Defects: A holistic systematic review (Accepted, PubMed indexed)Additionally, I have four articles submitted for publication and five more in preparation for submission before January 2024.

 

RESEARCH PROJECTS 🔬

Effect of Personality Types on Heart Disease Prognosis: A systematic review.Incidence of Infections in Children with Leukemia: Conducted at Bandar Abbas Children’s Hospital (2020-2023).Neonatal Neutropenia and Leukopenia: Study in infants admitted to Shariati Bandar Abbas Hospital (2021-2023).Prevalence of Hepatitis B, C, and D: In thalassemia patients referred to Aburihan Center, Bandar Abbas.Burns from Alkaline Substance Ingestion: Cases studied at Bandar Abbas Children’s Hospital (2019-2023)

 

REVIEWER EXPERIENCE 🏅

Reviewer for a cohort article published in the Italian Pediatric JournalReviewer for the Tobacco Congress held at Hormozgan Medical Sciences University (March 2022).Active reviewer for Hematology, Immunology, and Pediatric departments at Hormozgan Medical Sciences University (4 recommendation letters available)

 

📚 Publications

  • Title: Dental Pulp Stem Cells Regenerate Neural Tissue in Degenerative Disorders and Stroke Rehabilitation: A Scope Systematic Review
    Authors: Rahnama Sisakht, A., Tavasouli, Z., Negahi, A., Hosseini, S.A., Satarzadeh, M.
    Year: 2024
    Journal: Heliyon, Volume 10, Issue 15, e35080

 

  • Title: Mothers’ Health-Seeking Behaviors and Ignorance of Children’s Fever: A Cross-Sectional Study
    Authors: Tariverdi, M., Sakhtemanpour Bolouki, S., Tamaddondar, M., Rahmati, M.B., Mohammadian, M.
    Year: 2024
    Journal: Archives of Pediatric Infectious Diseases, Volume 12, Issue 3, e142885

 

  • Title: Maternal Smoking during Pregnancy and its Effects on Neural Tube Defects
    Authors: Elahi, Z., Hassanzadeh, F., Satarzadeh, M.
    Year: 2024
    Journal: Iranian Journal of Child Neurology, Volume 18, Issue 3, Pages 103–115

 

Conclusion

Mohammad’s academic background, research contributions, and determination to overcome challenges in the Iranian academic environment position him as a strong candidate for postgraduate studies. His pursuit of international education aims to broaden his expertise, offering him the opportunity to expand his research capabilities and contribute to global medical knowledge. His drive, research skills, and experience in the medical field align well with his career aspirations, making him a promising candidate for further academic and professional growth in healthcare.